Aktuelle News
News Funktionen
Weitere Funktionen
10 Juni 2015
ALK-Abelló
ALK’s partner, MSD, publishes Phase II data on house dust mite SLIT-tablet in leading allergy journal journal
4 Juni 2015
ALK-Abelló
ALK announces top-line results from its partner MSD’s North American Phase III trial of house dust mite SLIT-tablet
1 Juni 2015
ALK-Abelló
Report on Management’s transactions with ALK-Abelló A/S B-shares and associated securities
27 Mai 2015
ALK-Abelló
CORRECTION: ALK to present at two upcoming 2015 Investor Conferences
ALK-Abelló
ALK to present at two upcoming 2015 Investor Conferences
5 Mai 2015
ALK-Abelló
Three-month interim report (Q1) 2015
30 April 2015
ALK-Abelló
Release date of three-month interim report (Q1) 2015 for ALK
16 März 2015
ALK-Abelló
Report on Management’s transactions with ALK-Abelló A/S B shares and as-sociated securities
ALK-Abelló
Grant of share options and conditional shares to members of the Board of Management and key employees
12 März 2015
ALK-Abelló
Annual general meeting of ALK-Abelló A/S held on 12 March 2015
16 Februar 2015
ALK-Abelló
Annual General Meeting in ALK-Abelló A/S on 12 March 2015
9 Februar 2015
ALK-Abelló
ALK and bioCSL enter into a partnership for allergy
ALK-Abelló
ALK releases its annual report 2014
3 Februar 2015
ALK-Abelló
Release of annual report 2014 and audio cast
26 Januar 2015
ALK-Abelló
ALK’s partner, Torii, submits registration application for the house dust mite SLIT-tablet in Japan
16 Dezember 2014
ALK-Abelló
ALK – Financial calendar for the 2015 financial year
25 November 2014
ALK-Abelló
Notification of ownership in ALK
20 November 2014
ALK-Abelló
ALK submits registration application for house dust mite SLIT-tablet in Europe
14 November 2014
ALK-Abelló
Nine-month interim report (Q3) 2014
11 November 2014
ALK-Abelló
ALK to present at Jefferies 2014 Global Healthcare Conference in London
10 November 2014
ALK-Abelló
Release date of nine-month interim report (Q3) 2014 for ALK
1 Oktober 2014
ALK-Abelló
Report on Management’s transactions with ALK-Abelló A/S B-shares and associated securities
12 September 2014
ALK-Abelló
Report on Management’s transactions with ALK-Abelló A/S B-shares and associated securities
ALK-Abelló
Grant of conditional shares to members of the Board of Management and key employees
2 September 2014
ALK-Abelló
ALK’s partner Torii initiates final stage of clinical development of Japanese cedar SLIT-tablet
28 August 2014
ALK-Abelló
ALK to participate at the Goldman Sachs European Biotech Symposium in London
27 August 2014
ALK-Abelló
ALK to present at the Morgan Stanley Global Healthcare Conference in New York
19 August 2014
ALK-Abelló
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
13 August 2014
ALK-Abelló
Six-month interim report (Q2) 2014
6 August 2014
ALK-Abelló
Release date of six-month interim report (Q2) 2014 for ALK